| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 5 |
| 1 | FLUTICASONE PROPIONATE | 4 |
| 2 | GABAPENTIN | 4 |
| 3 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 4 |
| 4 | PANTOPRAZOLE SODIUM | 4 |
| 5 | PREDNISONE | 4 |
| 6 | ACETAMINOPHEN | 3 |
| 7 | ACETAMINOPHEN 500MG | 3 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 3 |
| 9 | LISINOPRIL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THROMBIN HUMAN AND FIBRINOGEN | 2 | 0.0060 |
| 1 | USTEKINUMAB-STBA | 1 | 0.0027 |
| 2 | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | 1 | 0.0012 |
| 3 | INSULIN ASPART INJECTION | 1 | 0.0004 |
| 4 | SENNOSIDES AND DOCUSATE SODIUM | 1 | 0.0003 |
| 5 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 6 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 4 | 0.0003 |
| 7 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 1 | 0.0003 |
| 8 | FINERENONE | 1 | 0.0003 |
| 9 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 1 | Corticosteroid [EPC] | 4 |
| 2 | Opioid Agonist [EPC] | 4 |
| 3 | GLP-1 Receptor Agonist [EPC] | 3 |
| 4 | Insulin Analog [EPC] | 3 |
| 5 | Amide Local Anesthetic [EPC] | 2 |
| 6 | Antiarrhythmic [EPC] | 2 |
| 7 | Antirheumatic Agent [EPC] | 2 |
| 8 | Benzodiazepine [EPC] | 2 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 2 | 0.0024 |
| 1 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 3 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 4 | Radiographic Contrast Agent [EPC] | 1 | 0.0000 |
| 5 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 6 | Amide Local Anesthetic [EPC] | 2 | 0.0000 |
| 7 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 8 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 9 | Antiarrhythmic [EPC] | 2 | 0.0000 |